Andrea Odersky
Essen University Hospital(DE)West German Heart and Vascular Center Essen(DE)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Neuroblastoma Research and Treatments, CAR-T cell therapy research, Ubiquitin and proteasome pathways, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Mutational dynamics between primary and relapse neuroblastomas(2015)315 cited
- → Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice(2012)178 cited
- → Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2015)178 cited
- → Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy(2021)152 cited
- → BET bromodomain protein inhibition is a therapeutic option for medulloblastoma(2013)142 cited
- → MiR‐137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A(2013)116 cited
- → miR‐542‐3p exerts tumor suppressive functions in neuroblastoma by downregulating S urvivin(2014)83 cited
- → The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV(2007)52 cited
- → The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models(2016)44 cited
- → Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells(2014)37 cited